Literature DB >> 9128815

Neonatal haemochromatosis: report of a patient with favourable outcome.

J Müller-Berghaus1, A S Knisely, R Zaum, A Vierzig, E Kirn, D V Michalk, B Roth.   

Abstract

UNLABELLED: A male newborn was referred on the 2nd day of life because of suspected sepsis. The child became comatose and ventilator dependent owing to progressive hepatic failure with hyperammonaemia. Diagnostic studies revealed an highly elevated ferritin level. The family history was remarkable in that an aunt and a great aunt on his mother's side have idiopathic haemochromatosis. Open liver biopsy showed advanced cirrhosis with cholestasis and excessive hepatocellular siderosis. Concentrations of iron in liver tissue were highly elevated. The child's status improved unexpectedly, and excretory and synthetic liver function gradually returned to normal.
CONCLUSION: Neonatal haemochromatosis is not an irreversible disease of iron metabolism but rather a distinct outcome of fetal liver disease which predisposes by an yet unknown mechanism to a derangement of fetoplacental iron handling. If patients survive the initial phase of liver failure, prognosis is largely dependent upon liver cirrhosis and its sequels. The iron overload in this type of haemochromatosis is reversible and not progressive.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128815     DOI: 10.1007/s004310050604

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

1.  Identification of neonatal liver failure and perinatal hemochromatosis in Canada.

Authors:  R Jackson; E A Roberts
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

2.  Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism.

Authors:  A L Kelly; P W Lunt; F Rodrigues; P J Berry; D M Flynn; P J McKiernan; D A Kelly; G Mieli-Vergani; T M Cox
Journal:  J Med Genet       Date:  2001-09       Impact factor: 6.318

3.  Progress in treatment and outcome for children with neonatal haemochromatosis.

Authors:  D M Flynn; N Mohan; P McKiernan; S Beath; J Buckels; D Mayer; D A Kelly
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

Review 4.  New management options for end-stage chronic liver disease and acute liver failure: potential for pediatric patients.

Authors:  Dominique Debray; Nadya Yousef; Philippe Durand
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

5.  Neonatal haemochromatosis associated with gastroschisis.

Authors:  M P Thornton; S S Marven; M S Tanner; B Gürtl-Lackner
Journal:  Pediatr Surg Int       Date:  2008-03-13       Impact factor: 1.827

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.